Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:12 PM
Ignite Modification Date:
2025-12-24 @ 2:12 PM
NCT ID:
NCT07167095
Eligibility Criteria:
Inclusion Criteria:
* Age ≥18 years
* Pathologically confirmed stage IV (metastatic) solid malignancy
* Followed at Etlik City Hospital, Department of Medical Oncology
* Presented to the emergency department between December 2022 and March 2025
* Either discharged on the same day, admitted to the hospital, or died during the ED visit
* Received systemic anticancer therapy (chemotherapy, immunotherapy, targeted therapy, or hormonal therapy) within the past 6 months
* Availability of complete clinical and laboratory data
Exclusion Criteria:
* Stage I-III cancer patients
* Patients not receiving systemic therapy, only palliative/supportive care
* Patients followed in other oncology centers but presenting to Etlik City Hospital ED
* Patients with hematologic malignancies (e.g., leukemia, lymphoma, multiple myeloma)
* Patients with missing clinical or laboratory data
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07167095
Study Brief:
Protocol Section:
NCT07167095